2017-08-01T18:03:01+03:00[Europe/Moscow] en true Ebola virus disease treatment research, Post-Ebola virus syndrome, BCX4430, CAd3-ZEBOV, FGI-106, VSV-EBOV, JK-05, ZMapp, FGI-103, FGI-104, Brincidofovir, Favipiravir flashcards Ebola
Click to flip
  • Ebola virus disease treatment research
    Ebola virus disease, or simply Ebola, is a disease of humans and other primates caused by ebolaviruses.
  • Post-Ebola virus syndrome
    Post-Ebola virus syndrome (or post-Ebola syndrome) is a post-viral syndrome affecting those who have recovered from infection with Ebola.
  • BCX4430
    BCX4430 (Immucillin-A) is an antiviral drug, an adenosine analog (a type of nucleoside analog).
  • CAd3-ZEBOV
    cAd3-ZEBOV (also known as the NIAID/GSK Ebola vaccine or cAd3-EBO Z) is an experimental vaccine for two ebolaviruses, Ebola virus and Sudan virus, developed by scientists at GlaxoSmithKline (GSK) and tested by National Institute of Allergy and Infectious Disease (NIAID).
  • FGI-106
    FGI-106 is a broad-spectrum antiviral drug developed as a potential treatment for enveloped RNA viruses, in particular viral hemorrhagic fevers from the bunyavirus, flavivirus and filovirus families.
    Vesicular Stomatitis Virus-Ebola Virus vaccine — known as VSV-EBOV — is an experimental vaccine for protecting against Ebola virus disease.
  • JK-05
    JK-05 is a broad-spectrum antiviral drug developed by the Chinese company Sihuan Pharmaceutical along with the Chinese Academy of Military Medical Sciences.
  • ZMapp
    ZMapp is an experimental biopharmaceutical drug comprising three chimeric monoclonal antibodies under development as a treatment for Ebola virus disease.
  • FGI-103
    FGI-103 is an antiviral drug developed as a potential treatment for the filoviruses Ebola virus and Marburg virus.
  • FGI-104
    FGI-104 is the name for a family of chemical compounds that act as broad-spectrum antiviral drugs, with activity against a range of viruses including Hepatitis B, Hepatitis C, HIV, Ebola virus and Venezuelan equine encephalitis virus.
  • Brincidofovir
    Brincidofovir (CMX001) is an experimental antiviral drug being developed by Chimerix of Durham, NC, for the treatment of cytomegalovirus, adenovirus, smallpox, and ebolavirus infections.
  • Favipiravir
    Favipiravir, also known as T-705 or Avigan, is an experimental antiviral drug being developed by Toyama Chemical of Japan with activity against many RNA viruses.